BCHE and early-onset autosomal dominant Alzheimer disease: The treatment of dementia is dependent on the etiology and stage of the condition.[6,34] Cholinesterase inhibitors, memantine, and antiamyloid (Aβ) immunomodulators are utilized to moderately slow cognitive decline in patients with Alzheimer disease or mild dementia.[35] Nonpharmacological interventions, such as identifying triggers and implementing personalized behavioral therapies, are preferred for managing psychiatric and behavioral symptoms associated with dementia.